June 25, 2024 · Form 4 insider transaction
Arif Bilal sold 3,898 shares of Sarepta Therapeutics, Inc. at $163.23 per share, a transaction worth $636.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024.